Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.85 -0.07 (-0.59%)
At close: Nov 11, 2026 · 4:00 PM EST

Zevra Therapeutics (ZVRA) Common Stock Issued (2015 - 2026)

Updated

Zevra Therapeutics (ZVRA) reported Common Stock Issued of $1.58 million for Q3 2026, down 75.8% from $6.53 million a year earlier but up 263.2% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Common Stock Issued (2015 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Zevra Therapeutics' Common Stock Issued came in at $14.48 million, up 35.5% year-over-year; for FY2025, it was $12.44 million, down 81.5% from FY2024.

  • Common Stock Issued has a four-year compound annual growth rate of -42.9% (FY2021 to FY2025).
  • By year, Common Stock Issued came in at $67.26 million in FY2024 (+963.5%), $6.32 million in FY2023, $324,000 in FY2022 (-99.7%) and $116.86 million in FY2021.
  • Five-year quarterly Common Stock Issued spans a low of $53,000 in Q3 2023 and a high of $64.77 million in Q3 2024.
  • Year over year, Common Stock Issued gained in four of the last eight quarters, with growth averaging 68.8%.
  • The high point for year-over-year Common Stock Issued in five years was Q1 2026 (growth of 401.4%); the low point was Q3 2025 (a decline of 89.9%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $435,000 (Q2 2026), $9.92 million (Q1 2026) and $2.55 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 743.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 247.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 87.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zevra Therapeutics 708.52 Mn -100.24 Mn 36.01 Mn 1.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.58 Mn
Jun 30, 2026 435,000.00
Mar 31, 2026 9.92 Mn
Dec 31, 2025 2.55 Mn
Sep 30, 2025 6.53 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 796,000.00
Sep 30, 2024 64.77 Mn
Jun 30, 2024 480,000.00
Mar 31, 2024 1.22 Mn
Dec 31, 2023 6.11 Mn
Sep 30, 2023 53,000.00
Jun 30, 2023 166,000.00
Dec 31, 2022 108,000.00
Jun 30, 2022 216,000.00
Sep 30, 2021 77.76 Mn
Mar 31, 2021 74.88 Mn
Dec 31, 2018 23.50 Mn
Sep 30, 2018 836,000.00
API Access

Zevra Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ZVRA&period=max&api_key=YOUR_API_KEY